Breast Cancer Clinical Trials

Showing 3021-3040 of 4,817 trials

Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer

NCT00706615

RATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of vaccine therapy in treating women with previously treated metastatic breast cancer.

Breast Cancer

Jonsson Comprehensive Cancer CenterStarted Jul 2008

Los Angeles, California, United States

COMPLETEDNA

Study of ESR1 Mutations in Metastatic Breast Cancer

NCT02473120

The purpose of the study is to determine the frequency ESR1 mutations by Digital PCR in patient with metastatic breast cancer.

Metastatic Breast Cancer

Centre Henri Becquerel104 participantsStarted Jun 2015

Rouen, France

COMPLETEDPhase 2

Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate

NCT02581839

Subjects are asked to take part in a clinical research study that tests Eribulin, a new drug. Eribulin is an investigational (experimental) anti-cancer agent that has not been approved by the Food and Drug Administration (FDA) for use in patients with brain metastases. Eribulin is FDA approved for use in patients with metastatic breast cancer but the effect it may or may not have on brain metastases has not been studied.

Metastatic Breast CancerBrain Metastases

Case Comprehensive Cancer Center9 participantsStarted Nov 2015

Cleveland, Ohio, United States • Cleveland, Ohio, United States

Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer

Study of ESR1 Mutations in Metastatic Breast Cancer

Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate

Related Searches

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer

Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

Whole Breast Irradiation vs Twice Daily vs. Once Daily Accelerated Partial Breast Irradiation

Post-Mastectomy Analgesia Using Exparel (Liposomal) Versus Standard Bupivacaine or Placebo

Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer

Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer

Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

Telenursing and Breast Cancer: The Turkish Case

A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors

Guide for Prioritisation of Patients for Referral to Breast Clinics

Diagnosis and Prediction of Taxanes Induced Cardiac Dysfunction

Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer

Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer

Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer

Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer